Insmed
INSM
103 hedge funds and large institutions have $619M invested in Insmed in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 27 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
29% more call options, than puts
Call options by funds: $27.6M | Put options by funds: $21.4M
2.15% more ownership
Funds ownership: 76.79% → 78.95% (+2.2%)
7% more capital inflows, than outflows
Capital inflows: $114M | Capital outflows: $106M
7% less funds holding
Funds holding: 111 → 103 (-8)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Perceptive Advisors
New York
|
+$21.6M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$12.1M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$12M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$9.56M |
| 5 |
OrbiMed
New York
|
+$7.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$31.5M |
| 2 |
Deerfield Management
New York
|
-$12M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$8.7M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.91M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$3.7M |
INSM Hedge Fund Activity: Q2 2014 in Review
103 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2014, worth a combined $619M — up 8% from $573M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of INSM and 19 opened new positions — a net loss of 8 holders — while 30 trimmed existing stakes and 43 added.
The largest buyer was Perceptive Advisors, adding an estimated $21.6M. The largest seller was Wells Fargo, cutting an estimated $31.5M.
- 103 institutional investors held Insmed (INSM) as of Q2 2014, down from 111 in Q1 2014.
- Funds reported $619M of Insmed stock for Q2 2014, up 8% quarter-over-quarter.
- 19 funds opened new Insmed positions in Q2 2014 and 27 closed out, a net change of -8 holders.
- The largest Insmed buyer in Q2 2014 was Perceptive Advisors, an estimated $21.6M added.
- The largest Insmed seller in Q2 2014 was Wells Fargo, an estimated $31.5M sold.
Based on aggregated 13F filings for Q2 2014.